Cabaletta Bio (CABA) Operating Expenses (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Operating Expenses of $42.6 million for Q4 2025, up 26.12% year-over-year from $33.8 million in Q4 2024, and down 8.54% quarter-over-quarter from $46.6 million in Q3 2025.
Cabaletta Bio (CABA) Operating Expenses (2018 - 2026) Analysis & Trends
Cabaletta Bio's Operating Expenses history runs 8 years deep, the most recent figure standing at $42.6 million for Q4 2025.
- In Q4 2025, Operating Expenses rose 26.12% year-over-year to $42.6 million; the TTM figure through Dec 2025 stood at $172.2 million (up 37.64% YoY), while the FY2025 annual figure was $172.2 million, up 37.64% from the prior year.
- Operating Expenses for Q4 2025 stood at $42.6 million, down from $46.6 million in the prior quarter.
- The five-year high for Operating Expenses was $46.6 million in Q3 2025, with the low at $9.7 million in Q1 2021.
- The 5-year median for Operating Expenses is $17.8 million (2023), against an average of $23.6 million.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses advanced 1.86% in 2022, then surged 90.55% in 2024.
- Cabaletta Bio's Operating Expenses stood at $13.9 million in 2021, then increased by 17.34% to $16.3 million in 2022, then surged by 41.98% to $23.1 million in 2023, then jumped by 45.96% to $33.8 million in 2024, then gained by 26.12% to $42.6 million in 2025.
- Business Quant data shows CABA's Operating Expenses at $42.6 million in Q4 2025, $46.6 million in Q3 2025, and $45.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 52.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.02 Mn |
| Dec 31, 2025 | 42.61 Mn |
| Sep 30, 2025 | 46.59 Mn |
| Jun 30, 2025 | 45.91 Mn |
| Mar 31, 2025 | 37.14 Mn |
| Dec 31, 2024 | 33.79 Mn |
| Sep 30, 2024 | 33.05 Mn |
| Jun 30, 2024 | 30.28 Mn |
| Mar 31, 2024 | 28.03 Mn |
| Dec 31, 2023 | 23.15 Mn |
| Sep 30, 2023 | 18.67 Mn |
| Jun 30, 2023 | 15.89 Mn |
| Mar 31, 2023 | 16.96 Mn |
| Dec 31, 2022 | 16.30 Mn |
| Sep 30, 2022 | 11.78 Mn |
| Jun 30, 2022 | 13.06 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | 13.89 Mn |
| Sep 30, 2021 | 11.56 Mn |
| Jun 30, 2021 | 11.15 Mn |